2Kohorn EI. Worldwide survey of the results of treating gesta- tional trophoblastic disease [J]. Reprod Med, 2014, 59 (3- 4) : 145-153.
3Cowllin P,Diatta AL,Boufettal H,et al. The involment of trans-generational effect in the high incidence of the hyda- tidiform mole in Africa[J]. Placenta,2015,36( 1 ) :48-51.
4Akoury E, Zhang L, Ao A, et al. NLRP7 and KHDC3L, the two maternal effct proteins responsible for recurrent hy- datidiform moles,co-localize to the ooeyte cytoskeleton[J]. Hum Reprod, 2015,30( 1 ) : 159-169.
6Nirmala CK, Nor Azlin MI, Harry SR,et al. Outcome of molar pregnancies in Malaysia: a tertiary centre experience[J]. J Obstet Gynaecol, 2013,33(2) : 191-193.
8Petts G, Fisher RA, Short D, et al. Histopathological and immunohistochemical features of early hydatidiform mole in relation to subsequent development of persistent gestational trophoblastic disease[J]. J Reprod Med,2014,59 (5-6): 213 -220.
二级参考文献12
1Berkowitz RS, Goldstein DP. Clinical practice molar pregnancy [ J]. N Engl J Med ,2009,360 : 1639-1645.
2Goto S, Yamada A, lshizuka T, et al. Development of postmolar trophoblastic disease after partial molar pregnancy [ J ]. Gynecol Oncol, 1993,48 : 165-170.
4Park TK, Kim SN. Lee SK. Analysis of risk factors for postmolar trophoblastie disease: categorization of risk factors and effect of prophylactic chemotherapy [ J ]. Yonsei Med J, 1996,37 : 412- 419.
9Charlie A. Amezcua,Afshin Bahador,Yathi M. Naidu,Juan C. Felix.Expression of human telomerase reverse transcriptase, the catalytic subunit of telomerase, is associated with the development of persistent disease in complete hydatidiform moles[J].American Journal of Obstetrics and Gynecology.2001(7)
